-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80

Benzinga·10/19/2026 13:04:20
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $65 to $80.